Influence of lifelong dietary fats on the brain fatty acids and amphetamine-induced behavioral responses in adult rat

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 45, Issue , 2013, Pages 215-222

  Trevizol, F ^a   Roversi, K ^a   Dias, V T ^a   Roversi, Kr ^a   Pase, C S ^a   Barcelos, R C S ^a   Benvegnu, D M ^a   Kuhn, F T ^a   Dolci, G S ^a   Ross, D H ^a   Veit, J C ^a   Piccolo, J ^a   Emanuelli, T ^a   Burger M E ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Bipolar disorder; Mania; Oxidative damage; Reactive species; Trans fat

Indexed keywords

AMPHETAMINE; BRAIN PROTEIN; DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL; HYDROGENATED VEGETABLE OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; PROTEIN CARBONYL; REACTIVE OXYGEN METABOLITE; SOYBEAN OIL; UNCLASSIFIED DRUG;

ADULT ANIMAL; ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BIOCHEMISTRY; BRAIN CORTEX; BRAIN DAMAGE; BRAIN FUNCTION; BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE EXACERBATION; FAT INTAKE; FOOD COMPOSITION; HIPPOCAMPUS; LOCOMOTION; MALE; MANIA; MEMORY; MENTAL PERFORMANCE; NEUROPROTECTION; NONHUMAN; OXIDATION REDUCTION REACTION; RAT;

Α-LINOLENIC ACID; ALA; AMPH; AMPHETAMINE; ARA; ARACHIDONIC ACID; BIPOLAR DISORDER; BP; DHA; DOCOSAHEXAENOIC ACID; EFA; EICOSAPENTAENOIC ACID; EPA; ESSENTIAL FATTY ACIDS; FA; FATTY ACIDS; FISH OIL; FO; HVF; HYDROGENATED VEGETABLE FAT; LA; LC-PUFA; LINOLEIC ACID; LONG CHAIN POLYUNSATURATED FATTY ACIDS; MANIA; MONOUNSATURATED FATTY ACIDS; MUFA; NORT; NOVEL RECOGNITION TASK; OXIDATIVE DAMAGE; PC; POLYUNSATURATED FATTY ACIDS; PROTEIN CARBONYL; PUFA; REACTIVE SPECIES; RS; SO; SOYBEAN OIL; TFA; TRANS FAT; TRANS FATTY ACIDS;

AMPHETAMINE; ANIMALS; BIPOLAR DISORDER; BRAIN; CEREBRAL CORTEX; CORPUS STRIATUM; DIETARY FATS; EXPLORATORY BEHAVIOR; FATTY ACIDS; FEMALE; HIPPOCAMPUS; MALE; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; PREGNANCY; RATS; REACTIVE OXYGEN SPECIES; RECOGNITION (PSYCHOLOGY);

EID: 84880021247     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2013.06.007     Document Type: Article

References (72)

1. Acar N., Chardigny J.M., Darbois M., Pasquis B., Śb́dio J.M. Modification of the dopaminergic neurotransmitters in striatum, frontal cortex and hippocampus of rats fed for 21months with trans isomers of ?-linolenic acid. Neurosci Res 2003, 45:375-382.
2. Andreazza A.C., Cassini C., Rosa A.R., Leite M.C., de Almeida L.M., Nardin P., et al. Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res 2007, 41:523-529.
3. Bagga D., Wang L., Farias-Eisner R., Glaspy J.A., Reddy S.T. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci U S A 2003, 100:1751-1756.
4. Barcelos R.C.S., Benvegnú D.M., Boufleur N., Reckziegel P., Muller L.G., Pase C., et al. Effects of ?-3 essential fatty acids (?-3 EFAs) on motor disorders and memory dysfunction typical neuroleptic-induced: behavioral and biochemical parameter. Neurosci Res 2010, 17:228-237.
5. Barcelos R.C.S., Benvegnú D.M., Boufleur N., Pase C., Teixeira A.M., Reckziegel P., et al. Short term dietary fish oil supplementation improves motor deficiencies related to reserpine-induced parkinsonism in rats. Lipids 2011, 46:143-149.
6. Benatti P., Peluso G., Nicolai R., Calvani M. Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties. J Am Coll Nutr 2004, 23:281-302.
7. Berk M., Kapczinski F., Andreazza A.C., Dean O.M., Giorlando F., Maes M., et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 2011, 35:804-817.
8. Berman S.B., Hastings T.G. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. J Neurochem 1999, 73:1127-1137.
9. Bhattacharjee A.K., Chang L., Chen M., White L., Bell J.M., Bazinet R.P., et al. Chronic d-amphetamine depresses an imaging marker of arachidonic acid metabolism in rat brain. Int J Neuropsychopharmacol 2008, 11:957-969.
10. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959, 37:911-917.
11. Bourre J.M., Francois M., Youyou A., Dumont O., Piciotti M., Pascal G., et al. The effects of dietary alpha-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. J Nutr 1989, 119:1880-1892.
12. Chalon S. Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids 2006, 75:259-269.
13. Chalon S., Delion-Vancassel S., Belzung C., Guilloteau D., Leguisquet A.M., Besnard J.C., et al. Dietary fish oil affects monoaminergic neurotransmission and behavior in rats. J Nutr 1998, 128:2512-2519.
14. Coyle J.T., Duman R.S. Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 2003, 38:157-160.
15. De Leon J., Tracy J., McCann E., McGrory A. Polydipsia and schizophrenia in a psychiatric hospital: a replication study. Schizophr Res 2002, 57:293-301.
16. De Lima M.N., Laranja D.C., Caldana F., Brombergg E., Roesler R., Schröder N. Reversal of age-related deficits in object recognition memory in rats with l-deprenyl. Exp Gerontol 2005, 40:506-511.
17. De Souza A.S., Rocha M.S., Carmo M.G.T. Effects of a normolipidic diet containing trans fatty acids during perinatal period on the growth, hippocampus fatty acid profile, and memory of Young rats according to sex. Nutrition 2012, 28:458-464.
18. Fernstrom J.D. Effects of dietary polyunsaturated fatty acids on neuronal function. Lipids 1999, 34:161-169.
19. Ferraz A.C., Delattre A.M., Almendra R.G., Sonagli M., Borges C., Araujo P., et al. Chronic ?-3 fatty acids supplementation promotes beneficial effects on anxiety, cognitive and depressive-like behaviors in rats subjected to a restraint stress protocol. Behav Brain Res 2011, 219:116-122.
20. Frey B.N., Martins M.R., Petronilho F.C., Dal-Pizzol F., Quevedo J., Kapezinski F. Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania. Bipolar Disord 2006, 8:275-280.
21. Frey B.N., Andreazza A.C., Kunz M., Gomes F.A., Quevedo J., Salvador M., et al. Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:283-285.
22. Ghule A.E., Jadhav S.S., Bodhankar S.L. Antiarrhythmic effect of flax lignan concentrate alone and concomitantly with omega 3 fatty acid mediated through inhibition of cardiomyocyte apoptosis in digoxin induced ventricular arrhythmia and lethality in rats. Biomed Aging Pathol 2012, 2:111-120.
23. Graham D.G., Tiffany S.M., Bell W.R., Gutknecht W.F. Autoxidation versus covalent binding of quinones as themechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol 1984, 14:644-653.
24. Grandgirard A., Piconneaux A., Sebedio J.L., Julliard F. Trans isomers of long-chain polyunsaturated fatty acids in tissue lipid classes of rats fed with heated linseed oil. Reprod Nutr Dev 1998, 38:17-29.
25. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 2001, 18:685-716.
26. Hartman L., Lago B.C. A rapid preparation of fatty methyl esters from lipids. Lab Pract 1973, 22:475-477.
27. Heldt A.S., Stanek L., Chhatwal J.P., Ressler K.J. Hippocampus specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol Psychiatry 2007, 12:656-670.
28. Hempel S.L., Buettner G.R.O., Malley Y.Q., Wessels D.A., Flaherty D.M. Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 20, 70-dichloro dihydrofluorescein diacetate, 5 (and 6)-carboxy-20, 70-dichloro dihydrofluorescein diacetate, and dihydrorhodamine 123. Free Radic Biol Med 1999, 27:146-159.
29. Herrera E. Implications of dietary fatty acids during pregnancy on placental, fetal and postnatal development - a review. Placenta 2002, 23:S9-S19.
30. Holub B.J. Clinical nutrition: 4. Omega-3 fatty acids in cardiovascular care. Can Med Assoc J 2002, 166:608-615.
31. Innis S.M. Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids. J Pediatr 2003, 143:S1-S8.
32. Innis S.M. Dietary (n?3) fatty acids and brain development. J Nutr 2007, 137:855-859.
33. Jump D.B. Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr Opin Lipidol 2002, 13:155-164.
34. Kerr D.S., Bevilaqua L.R., Bonini J.S., Rossato J.I., Kohler C.A., Medina J.H., et al. Angiotensin II blocks memory consolidation through an AT2 receptor dependent mechanism. Psychopharmacology 2005, 179:529-535.
35. Larque E., Perez-Llamas F., Puerta V., Giron M.D., Suarez M.D., Zamora S., et al. Dietary trans fatty acids affect docosahexaenoic acid concentrations in plasma and liver but not brain of pregnant and fetal rats. Pediatr Res 2000, 47:278-283.
36. Larque E., Garcia-Ruiz P.A., Perez-Llamas F., Zamora S., Gil A. Dietary transfatty acids alter the compositions of microsomes and mitochondria and the activities of microsome delta6-fatty acid desaturase and glucose-6-phosphatase in livers of pregnant rats. J Nutr 2003, 133:2526-2531.
37. Levine R.L., Williams J.A., Stadtman E.R., Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 1994, 233:346-357.
38. Lonergan P.E., Martin D.S., Horrobin D.F., Lynch M.A. Neuroprotective effect of eicosapentaenoic acid in hippocampus of rats exposed to gamma-irradiation. J Biol Chem 2002, 277:20804-20811.
39. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem 1951, 193:265-275.
40. Machado-Vieira R., Kapczinski F., Soares J.C. Perspectives for the development of animal models of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:209-224.
41. Magalhaes P.V., Kapczinski F., Nierenberg A.A., Deckersbach T., Weisinger D., Dodd S., et al. Illness burden and medical comorbidity in the systematic treatment enhancement program for bipolar disorder. Acta Psychiatr Scand 2012, 125:262-263.
42. Mahfouz M.M., Smith T., Kummerow F.A. Effect of dietary fats on desaturase activities and the biosynthesis of fatty acids in rat liver microsomes. Lipids 1984, 19:214-222.
43. Manji H.K., Drevets W.C., Charney D.S. The cellular neurobiology of depression. Nat Med 2001, 7:541-547.
44. Martin D.S., Lonergan P.E., Boland B., Fogarty M.P., Brady M., Horrobin D.F., et al. Apoptotic changes in the aged brain are triggered by interleukin-1beta-induced activation of p38 and reversed by treatment with eicosapentaenoic acid. J Biol Chem 2002, 277:34239-34246.
45. Martin D.S., Spencer P., Horrobin D.F., Lynch M.A. Long-term potentiation in aged rats is restored when the age-related decrease in polyunsaturated fatty acid concentration is reversed. Prostaglandins Leukot Essent Fatty Acids 2002, 67:121-130.
46. Mazza M., Pomponi M., Janiri L., Bria P., Mazza S. Omeg-3 fatty acids and antioxidants in neurological and psychiatric diseases: Na overview. Prog Neuropsychopharmacol Biol Psychiatry 2007, 21:12-26.
47. McCann U.D., Wong D.F., Yokoi F., Villemagne V., Dannals R.F., Ricaurte G.A. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11 C]WIN-35, 458. J Neurosci 1998, 18:8417-8422.
48. McGahon B.M., Martin D.S., Horrobin D.F., Lynch M.A. Age-related changes in synaptic function: analysis of the effect of dietary supplementation with omega-3 fatty acids. Neuroscience 1999, 94:305-314.
49. Merikangas K.R., Jin R., He J.P., Kessler R.C., Lee S., Sampson N.A., et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 2011, 68:241-251.
50. Mirnikjoo B., Brown S.E., Kim H.F., Marangell L.B., Sweatt J.D., Weeber E.J. Protein kinase inhibition by omega-3 fatty acids. J Biol Chem 2001, 276:10888-10896.
51. Morgado N., Galleguillos A., Sanhueza J., Garrido A., Nieto S., Valenzuela A. Effect of the degree of hydrogenation of dietary fish oil on the trans fatty acid content and enzymatic activity of rat hepatic microsomes. Lipids 1998, 33:669-673.
52. Neuringer M., Anderson G.J., Connor W.E. The essentiality of n?3 fatty acids for the development and function of the retina and brain. Annu Rev Nutr 1988, 8:517-541.
53. Palmieri B., Sblendorio V. Oxidative stress detection: what for? Part I. Eur Rev Med Pharmacol Sci 2006, 10:291-317.
54. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2007, Elsevier, Amsterdam. 6th ed.
55. Pettersen J., Opstvedt J. Trans fatty acids. 5. Fatty acid composition of lipids of the brain and other organs in suckling piglets. Lipids 1992, 27:761-769.
56. Rapoport S.I. In vivo fatty acid incorporation into brain phospholipids in relation to plasma availability, signal, transduction and membrane remodeling. J Mol Neurosci 2001, 16:243-262.
57. Richardson A.J., Ross M.A. Fatty acid metabolism in neurodevelopmental disorder: a new perspective on associations between attention-deficit/hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot Essent Fatty Acids 2000, 63:1-9.
58. Sarsilmaz M., Songur A., Ozyurt H., Kuş I., Ozen O.A., Ozyurt B., et al. Potential role of dietary omega-3 essential fatty acids on some oxidant/antioxidant parameters in rats' corpus striatum. Prostaglandins Leukot Essent Fatty Acids 2003, 69:253-259.
59. Simopoulos A.P. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991, 54:438-463.
60. Simopoulos A.P. Essential fatty acids in health and chronic disease. Am J Clin Nutr 1999, 70:560S-569S.
61. Simopoulos A.P. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 2002, 56:365-379.
62. Steckert A.M., Valvassori S.S., Moretti M., Dal-Pizzol F., Quevedo J. Role of oxidative stress in the pathophysiology of bipolar disorder. Neurochem Res 2010, 35:295-301.
63. Strakowski S.M., Sax K.W. Progressive behavioral response to repeated d-amphetamine challenge: further evidence for sensitization in humans. Biol Psychiatry 1998, 44:1171-1177.
64. Teixeira A.M., Pase C.S., Boufleur N., Roversi K., Barcelos R.C.S., Benvegnú D.M., et al. Exercise affects memory acquisition, anxiety-like symptoms and activity of membrane-bound enzyme in brain of rats fed with different dietary fats: impairments of trans fat. Neuroscience 2011, 195:80-88.
65. +-ATPase and catalase activity in rat striatum. Behav Brain Res 2012, 226:504-510.
66. Tinoco S.M.B., Sichieri R., Setta C.L., Moura A.S., do Carmo M.D. Trans fatty acids from milk of Brazilian mothers of premature infants. J Paediatr Child Health 2008, 44:50.
67. Trevizol F., Benvegnú D.M., Barcelos R.C.S., Boufleur N., Dolci G.S., Müller L.G., et al. Comparative study between n?6, trans and n?3 fatty acids on repeated amphetamine exposure: a possible factor for the development of mania. Pharmacol Biochem Behav 2011, 97:560-565.
68. Vancassel S., Durand G., Barthelemy C., Lejeune B., Martineau J., Guilloteau D., et al. Plasma fatty acid levels in autistic children. Prostaglandins Leukot Essent Fatty Acids 2001, 65:1-7.
69. Virgili F., Battistini N., Bini A., Vanninig V., Tomasi A. Dietary fatty acids composition modulates oxidative stress and cellular injury in the liver of CBrCl intoxicated rats. Nutr Res 1996, 16:1679-1688.
70. Wandall B. The controversy over trans fatty acids: effects early in life. Food Chem Toxicol 2008, 46:3571-3579.
71. Wauben I.P., Xing H.C., McCutcheon D., Wainwright P.E. Dietary trans fatty acids combined with a marginal essential fatty acid status during the pre- and postnatal periods do not affect growth or brain fatty acids but may alter behavioral development in B6D2F(2) mice. J Nutr 2001, 131:1568-1573.
72. Yehuda S., Rabinovitz S., Mostofsky D.I. Essential fatty acids and the brain: from infancy to aging. Neurobiol Aging 2005, 26:98-102.